Atlas Trials

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

Clinical trial NCT05010031 · RECRUITING

Trial details

NCT number
NCT05010031
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2021-08-11
Primary completion
2027-08-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.